West Pharmaceutical Services, I – Consensus Indicates Potential 14.4% Upside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

West Pharmaceutical Services, I found using ticker (WST) have now 5 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 515 and 405 calculating the average target price we see 457. With the stocks previous close at 399.55 this is indicating there is a potential upside of 14.4%. The 50 day moving average now sits at 416.11 and the 200 day MA is 403.09. The company has a market cap of $28,980m. You can visit the company’s website by visiting: https://www.westpharma.com

The potential market cap would be $33,147m based on the market concensus.

West Pharmaceutical Services designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search